qIRV

BIOLOGICAL2 trials

Sponsors

Pfizer

Conditions

HealthyInfluenza, Human

Phase 1

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza

CompletedNCT05052697

PfizerInfluenza, Human

Start: 2021-09-13End: 2023-01-27Updated: 2024-03-12

A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults

CompletedNCT05788237

Start: 2023-03-09End: 2023-09-27Updated: 2024-11-22

Related Papers

A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults

Vaccines2025-04-034 citations